Lisa H. Butterfield

Citat de

	Toate	Din 2020
Referințe bibliografice	21614	10024
h-index	73	43
i10-index	183	122

2100

1050

525

1575

199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202559 102 210 225 235 313 371 362 423 359 331 393 410 499 613 697 719 818 902 916 1224 1169 1717 2026 1961 1875 2040 394

Acces public

Afișați-le pe toate

123 de articole

5 articole

disponibile

indisponibile

Pe baza cerințelor privind finanțarea

Coautori

Antoni RibasUCLAAdresă de e-mail confirmată pe mednet.ucla.edu
Hideho OkadaProfessor of Neurological SurgeryAdresă de e-mail confirmată pe ucsf.edu
Pawel KalinskiProfessor and Chair, Immunology, Roswell Park Comprehensive Cancer CenterAdresă de e-mail confirmată pe roswellpark.org
Lazar VujanovicUniversity of PittsburghAdresă de e-mail confirmată pe upmc.edu
Wilson S. MengDuquesne UniversityAdresă de e-mail confirmată pe duq.edu
herbert zehUT SouthwesternAdresă de e-mail confirmată pe utsouthwestern.edu
Walter J. StorkusUniversity of PittsburghAdresă de e-mail confirmată pe upmc.edu
David A GellerUniversity of PittsburghAdresă de e-mail confirmată pe upmc.edu
Igor PuzanovRoswell Park Cancer InstituteAdresă de e-mail confirmată pe roswellpark.org
Gary KohanbashUniversity of Pittsburgh, Department of Neurological SurgeryAdresă de e-mail confirmată pe ucsf.edu
Robert L. FerrisUniversity of PittsburghAdresă de e-mail confirmată pe upmc.edu
Denise ReinkeUniversity of MichiganAdresă de e-mail confirmată pe med.umich.edu
Sandra P. D'AngeloMemorial Sloan Kettering Cancer CenterAdresă de e-mail confirmată pe mskcc.org
Fengmin ZhaoDana Farber Cancer InstituteAdresă de e-mail confirmată pe dfci.harvard.edu
Simon C WatkinsUniversity of PittsburghAdresă de e-mail confirmată pe pitt.edu
Alexander J. Lazar MD/PhDProfessor; Pathology, Genomic Medicine, Dermatology & Transl Molec Pathol, MD Anderson Cancer CtrAdresă de e-mail confirmată pe mdanderson.org
William GoodingUPMC Hillman Cancer CenterAdresă de e-mail confirmată pe pitt.edu
Steven DubinettUCLA School of MedicineAdresă de e-mail confirmată pe mednet.ucla.edu
Gordon FreemanDana-Farber Cancer Institute, Harvard Medical SchoolUnknown affiliationAdresă de e-mail confirmată pe dfci.harvard.edu
Howard KaufmanHarvard UniversityAdresă de e-mail confirmată pe mgh.harvard.edu

Urmăriți

Lisa H. Butterfield

Merck Research Laboratories

Adresă de e-mail confirmată pe merck.com

Cancer Immunotherapy


Titlu Sortați după descrierea bibliografică Sortați după an Sortați după titlu	Citat de Citat de	Anul
B cells and tertiary lymphoid structures promote immunotherapy response BA Helmink, SM Reddy, J Gao, S Zhang, R Basar, R Thakur, K Yizhak, ... Nature 577 (7791), 549-555, 2020	2099	2020
Pembrolizumab in advanced soft-tissue sarcoma and bone sarcoma (SARC028): a multicentre, two-cohort, single-arm, open-label, phase 2 trial HA Tawbi, M Burgess, V Bolejack, BA Van Tine, SM Schuetze, J Hu, ... The Lancet Oncology 18 (11), 1493-1501, 2017	1295	2017
Induction of CD8⁺ T-Cell Responses Against Novel Glioma–Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic … H Okada, P Kalinski, R Ueda, A Hoji, G Kohanbash, TE Donegan, ... Journal of clinical oncology 29 (3), 330-336, 2011	700	2011
Immunotherapy of cancer in 2012 JM Kirkwood, LH Butterfield, AA Tarhini, H Zarour, P Kalinski, S Ferrone CA: a cancer journal for clinicians 62 (5), 309-335, 2012	606	2012
A phase I/II trial testing immunization of hepatocellular carcinoma patients with dendritic cells pulsed with four α-fetoprotein peptides LH Butterfield, A Ribas, VB Dissette, Y Lee, JQ Yang, P De la Rocha, ... Clinical Cancer Research 12 (9), 2817-2825, 2006	603	2006
T-cell responses to HLA-A* 0201 immunodominant peptides derived from α-fetoprotein in patients with hepatocellular cancer LH Butterfield, A Ribas, WS Meng, VB Dissette, S Amarnani, HT Vu, ... Clinical Cancer Research 9 (16), 5902-5908, 2003	471	2003
Current developments in cancer vaccines and cellular immunotherapy A Ribas, LH Butterfield, JA Glaspy, JS Economou Journal of clinical oncology 21 (12), 2415-2432, 2003	420	2003
Ipilimumab plus sargramostim vs ipilimumab alone for treatment of metastatic melanoma: a randomized clinical trial FS Hodi, S Lee, DF McDermott, UN Rao, LH Butterfield, AA Tarhini, ... Jama 312 (17), 1744-1753, 2014	416	2014
A comparison of gene transfer methods in human dendritic cells. JF Arthur, LH Butterfield, MD Roth, LA Bui, SM Kiertscher, R Lau, ... Cancer Gene Therapy 4 (1), 17-25, 1997	415	1997
Baseline circulating IL-17 predicts toxicity while TGF-β1 and IL-10 are prognostic of relapse in ipilimumab neoadjuvant therapy of melanoma AA Tarhini, H Zahoor, Y Lin, U Malhotra, C Sander, LH Butterfield, ... Journal for immunotherapy of cancer 3, 1-6, 2015	388	2015
Dendritic cell–based cancer vaccines PM Santos, LH Butterfield The Journal of Immunology 200 (2), 443-449, 2018	379	2018
Soluble PD-L1 as a biomarker in malignant melanoma treated with checkpoint blockade J Zhou, KM Mahoney, A Giobbie-Hurder, F Zhao, S Lee, X Liao, S Rodig, ... Cancer immunology research 5 (6), 480-492, 2017	360	2017
Immune monitoring of the circulation and the tumor microenvironment in patients with regionally advanced melanoma receiving neoadjuvant ipilimumab AA Tarhini, H Edington, LH Butterfield, Y Lin, Y Shuai, H Tawbi, C Sander, ... PloS one 9 (2), e87705, 2014	336	2014
Determinant spreading associated with clinical response in dendritic cell-based immunotherapy for malignant melanoma LH Butterfield, A Ribas, VB Dissette, SN Amarnani, HT Vu, D Oseguera, ... Clinical Cancer Research 9 (3), 998-1008, 2003	331	2003
Cancer vaccines LH Butterfield Bmj 350, 2015	323	2015
Novel technologies and emerging biomarkers for personalized cancer immunotherapy J Yuan, PS Hegde, R Clynes, PG Foukas, A Harari, TO Kleen, P Kvistborg, ... Journal for immunotherapy of cancer 4, 1-25, 2016	292	2016
Next generation of immunotherapy for melanoma JM Kirkwood, AA Tarhini, MC Panelli, SJ Moschos, HM Zarour, ... Journal of Clinical Oncology 26 (20), 3445-3455, 2008	287	2008
Generation of human T-cell responses to an HLA-A2. 1-restricted peptide epitope derived from α-fetoprotein LH Butterfield, A Koh, W Meng, CM Vollmer, A Ribas, V Dissette, E Lee, ... Cancer research 59 (13), 3134-3142, 1999	260	1999
Identifying baseline immune-related biomarkers to predict clinical outcome of immunotherapy S Gnjatic, V Bronte, LR Brunet, MO Butler, ML Disis, J Galon, ... Journal for immunotherapy of cancer 5, 1-18, 2017	248	2017
α-Fetoprotein-specific genetic immunotherapy for hepatocellular carcinoma CM Vollmer Jr, FC Eilber, LH Butterfield, A Ribas, VB Dissette, A Koh, ... Cancer Research 59 (13), 3064-3067, 1999	239	1999

Sistemul nu poate realiza operația în acest moment. Încercați din nou mai târziu.

Articole 1–20

Referințe bibliografice pe an

Citate duplicat

Citate fuzionate

Adăugați coautoriCoautori

Urmăriți

Citat de

Coautori